Entry of influenza virus

Advances in Experimental Medicine and Biology

Volumn 790, Issue , 2013, Pages 72-82

  Sun, Xiangjie ^a   Whittaker, Gary R ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CLATHRIN; INFLUENZA VIRUS RECEPTOR; SIALIC ACID; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ARTICLE; BINDING AFFINITY; CYTOSOL; ENDOCYTOSIS; HOST; INFLUENZA; INFLUENZA VIRUS; MEMBRANE FUSION; MOLECULAR MECHANICS; NONHUMAN; PH; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS PARTICLE; VIRUS TRANSMISSION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ENDOCYTOSIS; HUMANS; MEMBRANE FUSION; ORTHOMYXOVIRIDAE; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

EID: 84881404691     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7651-1_4     Document Type: Article

References (80)

1. Lamb RA, Krug RM. Orthomyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams and Wilkins, 2001:1487-1531.
2. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 2000; 69:531-569.
3. Connor RJ, Kawaoka Y, Webster RG et al. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994; 205(1):17-23.
4. Matrosovich MN, Gambaryan AS, Teneberg S et al. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997; 233(1):224-234.
5. Rogers GN, D'Souza BL. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 1989; 173(1):317-322.
6. Carroll SM, Higa HH, Paulson JC. Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem 1981; 256(16):8357-8363.
7. Martin J, Wharton SA, Lin YP et al. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 1998; 241(1):101-111.
8. Sauter NK, Glick GD, Crowther RL et al. Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc Natl Acad Sci USA 1992; 89(1):324-328.
9. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981; 289(5796):366-373.
10. Fouchier RA, Munster V, Wallensten A et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005; 79(5):2814-2822.
11. Webster RG, Bean WJ, Gorman OT et al. Evolution and ecology of influenza virus. Microbiol Rev 1992; 56:152-179.
12. Claas EC, Osterhaus AD, van Beek R et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351(9101):472-477.
13. Koopmans M, Wilbrink B, Conyn M et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363(9409):587-593.
14. Lin YP, Shaw M, Gregory V et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci USA 2000; 97(17):9654-9658.
15. Baum LG, Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 1990; 40:35-38.
16. Ito T, Suzuki Y, Suzuki T et al. Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 2000; 74(19):9300-9305.
17. Suzuki Y, Ito T, Suzuki T et al. Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 2000; 74(24):11825-11831.
18. Matrosovich M, Zhou N, Kawaoka Y et al. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 1999; 73(2):1146-1155.
19. Matrosovich MN, Matrosovich TY, Gray T et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101(13):4620-4624.
20. Shinya K, Ebina M, Yamada S et al. Avian flu: Influenza virus receptors in the human airway. Nature 2006; 440(7083):435-436.
21. van Riel D, Munster VJ, de Wit E et al. H5N1 virus attachment to lower respiratory tract. Science 2006.
22. Gamblin SJ, Haire LF, Russell RJ et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004; 303(5665):1838-1842.
23. Ha Y, Stevens DJ, Skehel JJ et al. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci USA 2001; 98(20):11181-11186.
24. Ha Y, Stevens DJ, Skehel JJ et al. H5 avian and H9 swine influenza virus haemagglutinin structures: Possible origin of influenza subtypes. EMBO J 2002; 21(5):865-875.
25. Nobusawa E, Aoyama T, Kato H et al. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991; 182(2):475-485.
26. Vines A, Wells K, Matrosovich M et al. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol 1998; 72(9):7626-7631.
27. Glaser L, Stevens J, Zamarin D et al. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 2005; 79(17):11533-11536.
28. Stevens J, Blixt O, Tumpey TM et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006.
29. Ohuchi M, Ohuchi R, Feldmann A et al. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol 1997; 71(11):8377-8384.
30. Mir-Shekari SY, Ashford DA, Harvey DJ et al. The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. J Biol Chem 1997; 272(7):4027-4036.
31. Deom CM, Caton AJ, Schulze IT. Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proc Natl Acad Sci USA 1986; 83(11):3771-3775.
32. Gambaryan AS, Marinina VP, Tuzikov AB et al. Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology 1998; 247(2):170-177.
33. Stray SJ, Cummings RD, Air GM. Influenza virus infection of desialylated cells. Glycobiology 2000; 10(7):649-658.
34. Chu VC, Whittaker GR. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci USA 2004; 101(52):18153-18158.
35. Ablan S, Rawat SS, Blumenthal R et al. Entry of influenza virus into a glycosphingolipid-deficient mouse skin fibroblast cell line. Arch Virol 2001; 146(11):2227-2238.
36. Matrosovich M, Suzuki T, Hirabayashi Y et al. Gangliosides are not essential for influenza virus infection. Glycoconj J 2006; 23(1-2):107-113.
37. Paulson JC, Rogers GN. Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. Methods Enzymol 1987; 138:162-168.
38. Stevens J, Blixt O, Glaser L et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006; 355(5):1143-1155.
39. Dourmashkin RR, Tyrrell DA. Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol 1974; 24(1):129-141.
40. Matlin KS, Reggio H, Helenius A et al. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 1981; 91(3 Pt 1):601-613.
41. Sieczkarski SB, Whittaker GR. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol 2002; 76(20):10455-10464.
42. Sun X, Yau VK, Briggs BJ et al. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 2005; 338(1):53-60.
43. Rust MJ, Lakadamyali M, Zhang F et al. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 2004; 11(6):567-573.
44. Roy AM, Parker JS, Parrish CR et al. Early stages of influenza virus entry into Mv-1 lung cells: Involvement of dynamin. Virology 2000; 267(1):17-28.
45. Hoekstra D, Klappe K. Fluorescence assays to monitor fusion of enveloped viruses. In: Duzgunes N, ed. Methods in Enzymology, Vol. 220: Membrane Fusion Techniques Part A. San Diego: Academic Press, 1993:261-276.
46. Lakadamyali M, Rust MJ, Babcock HP et al. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci USA 2003; 100(16):9280-9285.
47. Sakai T, Ohuchi M, Imai M et al. Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells. J Virol 2006; 80(4):2013-2018.
48. Sieczkarski SB, Whittaker GR. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 2003; 4(5):333-343.
49. Sieczkarski SB, Brown HA, Whittaker GR. The role of protein kinase C bII in influenza virus entry via late endosomes. J Virol 2003; 77:460-469.
50. Khor R, McElroy LJ, Whittaker GR. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 2003; 4(12):857-868.
51. Lakadamyali M, Rust MJ, Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006; 124(5):997-1009.
52. Gottlieb TA, Ivanov IE, Adesnik M et al. Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells. J Cell Biol 1993; 120(3):695-710.
53. Choppin PW. Multiplication of two kinds of influenza A2 virus particles in monkey kidney cells. Virology 1963; 21:342-352.
54. Smirnov Yu A, Kuznetsova MA, Kaverin NV. The genetic aspects of influenza virus filamentous particle formation. Arch Virol 1991; 118(3-4):279-284.
55. Sieczkarski SB, Whittaker GR. Characterization of the host cell entry of filamentous influenza virus. Arch Virol 2005; 150(9):1783-1796.
56. Leikina E, Ramos C, Markovic I et al. Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J 2002; 21(21):5701-5710.
57. Puri A, Booy FP, Doms RW et al. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: Effects of acid pretreatment. J Virol 1990; 64(8):3824-3832.
58. Markovic I, Leikina E, Zhukovsky M et al. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J Cell Biol 2001; 155(5):833-844.
59. Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 1993; 73(4):823-832.
60. Colman PM, Lawrence MC. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 2003; 4(4):309-319.
61. Park HE, Gruenke JA, White JM. Leash in the groove mechanism of membrane fusion. Nat Struct Biol 2003; 10(12):1048-1053.
62. Han X, Bushweller JH, Cafiso DS et al. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol 2001; 8(8):715-720.
63. Hernandez LD, Hoffman LR, Wolfsberg TG et al. Virus-cell and cell-cell fusion. Ann Rev Cell Dev Biol 1996; 12:627-661.
64. Russell DG, Marsh M. Endocytosis in pathogen entry and replication. In: Marsh M, ed. Endocytosis. Oxford: Oxford University Press, 2001:247-280.
65. Danieli T, Pelletier SL, Henis YI et al. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol 1996; 133(3):559-569.
66. Takeda M, Leser GP, Russell CJ et al. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA 2003; 100(25):14610-14617.
67. Sun X, Whittaker GR. Role for influenza virus envelope cholesterol in virus entry and infection. J Virol 2003; 77(23):12543-12551.
68. Bui M, Whittaker G, Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 1996; 70:8391-8401.
69. Martin K, Helenius A. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 1991; 67:117-130.
70. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 1991; 65:232-244.
71. Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell 1992; 69:517-528.
72. Sugrue RJ, Hay AJ. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology 1991; 180:617-624.
73. Bukrinskaya AG, Vorkounova NK, Kornilayeva GV et al. Influenza virus uncoating in infected cells and effect of rimantadine. J Gen Virol 1982; 60:49-59.
74. Hay AJ, Wolstenholme AJ, Skehel JJ et al. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985; 4:3021-3024.
75. Whittaker GR, Digard P. Entry and transport of influenza virus. In: Kawaoka Y, ed. Influenza Virology. Current Topics. Wymondham, UK: Caister Academic press, 2006:37-64.
76. Cros JF, Garcia-Sastre A, Palese P. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic 2005; 6(3):205-213.
77. O'Neill RE, Jaskunas R, Blobel G et al. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 1995; 270:22701-22704.
78. Kemler I, Whittaker G, Helenius A. Nuclear import of microinjected influenza virus ribonucleoproteins. Virology 1994; 202:1028-1033.
79. Babcock HP, Chen C, Zhuang X. Using single-particle tracking to study nuclear trafficking of viral genes. Biophys J 2004; 87(4):2749-2758.
80. Russell RJ, Gamblin SJ, Haire LF et al. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 2004; 325(2):287-296.